Relationship Between Obesity, Alzheimer's Disease, and Parkinson's Disease: an Astrocentric View

被引:53
作者
Martin-Jimenez, Cynthia Alexandra [1 ]
Gaitan-Vaca, Diana Milena [1 ]
Echeverria, Valentina [2 ]
Gonzalez, Janneth [1 ]
Barreto, George E. [1 ,3 ]
机构
[1] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia
[2] Univ San Sebastian, Fac Ciencias Salud, Concepcion 1577, Chile
[3] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile
关键词
Astrocytes; Neuroinflammation; Obesity; Alzheimer's disease; Parkinson's disease; HIGH-FAT DIET; BODY-MASS INDEX; CENTRAL-NERVOUS-SYSTEM; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; COGNITIVE FUNCTION; OXIDATIVE STRESS; GLIAL-CELLS; INFLAMMATORY RESPONSES; MOLECULAR-MECHANISMS;
D O I
10.1007/s12035-016-0193-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Obesity is considered one of the greatest risk to human health and is associated with several factors including genetic components, diet, and physical inactivity. Recently, the relationship between obesity and numerous progressive and aging-related neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) have been observed. Thus, the involvement of the most abundant and heterogeneous group of glial cells in neurodegenerative diseases, the astrocytes, is caused by a combination of the failure on their normal homeostatic functions and the increase of toxic metabolites upon pathological event. Upon brain damage, molecular signals induce astrocyte activation and migration to the site of injury, entering in a highly active state, with the aim to contribute to ameliorating or worsening the pathology. In this regard, the aim of this review is to elucidate the relationship between obesity, Alzheimer's disease, and Parkinson's disease and highlight the role of astrocytes in these pathologies.
引用
收藏
页码:7096 / 7115
页数:20
相关论文
共 50 条
  • [41] Relationship between Alzheimer′s,Parkinson′s disease and Apolipoprotein E polymorphism in the Chinese
    QIN Bin ZENG Xiang yu GUO Han bang TANG Wei qing XU Rong HE Jian xin WANG Shu XU Xian hao Deptof NeurologyBeijing HospitalBeijing ChinaBiochemistry DivisionInstitute of Gerontal Medicine
    白求恩医科大学学报, 2001, (05) : 562 - 566
  • [42] Astrocytes in Alzheimer's Disease
    Verkhratsky, Alexei
    Olabarria, Markel
    Noristani, Harun N.
    Yeh, Chia-Yu
    Julio Rodriguez, Jose
    NEUROTHERAPEUTICS, 2010, 7 (04) : 399 - 412
  • [43] Responses to donepezil in Alzheimer's disease and Parkinson's disease
    Mori, S
    ALZHEIMER'S DISEASE: VASCULAR ETIOLOGY AND PATHOLOGY, 2002, 977 : 493 - 500
  • [44] Obesity, Diabetes, and Risk of Parkinson's Disease
    Palacios, Natalia
    Gao, Xiang
    McCullough, Marjorie L.
    Jacobs, Eric J.
    Patel, Alpa V.
    Mayo, Tinisha
    Schwarzschild, Michael A.
    Ascherio, Alberto
    MOVEMENT DISORDERS, 2011, 26 (12) : 2253 - 2259
  • [45] The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease
    Maiese, Kenneth
    CURRENT NEUROVASCULAR RESEARCH, 2023, 20 (03) : 314 - 333
  • [46] Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease
    Gruenblatt, Edna
    Riederer, Peter
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (02) : 83 - 90
  • [47] Cholesterol and obesity: A marker for Alzheimer's disease
    Sumithra, M.
    Ancy, P. M.
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2022, 11 (01): : 266 - 275
  • [48] Emerging Nanotechnology for Treatment of Alzheimer's and Parkinson's Disease
    Li, Amanda
    Tyson, Joel
    Patel, Shivni
    Patel, Meer
    Katakam, Sruthi
    Mao, Xiaobo
    He, Weiwei
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [49] Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease
    Reich, Niklas
    Holscher, Christian
    FRONTIERS IN NEUROENDOCRINOLOGY, 2024, 73
  • [50] Parkinson's and Alzheimer's disease: The surprising role of stress
    Rosch, PJ
    STRESS MEDICINE, 1999, 15 (01): : 1 - 8